Beschreibung

Study design overview for the randomized double-blind placebo-controlled trial evaluating partially hydrolyzed guar gum (PHGG) versus placebo in IBS patients over an 18-week period.

Figure 1

Flowchart

Source Paper

Randomized clinical study: Partially hydrolyzed guar gum (PHGG) versus placebo in the treatment of patients with irritable bowel syndrome.

Nutrition & metabolism (2016)

PMID: 26855665

DOI: 10.1186/s12986-016-0070-5

Cite This Figure

![Figure 1: Study design overview for the randomized double-blind placebo-controlled trial evaluating partially hydrolyzed guar gum (PHGG) versus placebo in IBS patients over an 18-week period.]()

> Source: E Niv et al. "Randomized clinical study: Partially hydrolyzed guar gum (PHGG) versus placebo i." *Nutrition & metabolism*, 2016. PMID: [26855665](https://pubmed.ncbi.nlm.nih.gov/26855665/)

<figure>
  <img src="" alt="Study design overview for the randomized double-blind placebo-controlled trial evaluating partially hydrolyzed guar gum (PHGG) versus placebo in IBS patients over an 18-week period." />
  <figcaption>Figure 1. Study design overview for the randomized double-blind placebo-controlled trial evaluating partially hydrolyzed guar gum (PHGG) versus placebo in IBS patients over an 18-week period.<br>  Source: E Niv et al. "Randomized clinical study: Partially hydrolyzed guar gum (PHGG) versus placebo i." <em>Nutrition & metabolism</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/26855665/">26855665</a></figcaption>
</figure>

Beschreibung

Figure 1

Source Paper

Cite This Figure

Verwandte Evidenz